 | • レポートコード：B-GIR08C4040 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、非腫瘍バイオ医薬品の世界市場について調べ、まとめました。種類別セグメントは、生物製剤、バイオシミラー等、用途別セグメントは、等に区分しました。非腫瘍バイオ医薬品の世界市場概観、企業動向、企業別非腫瘍バイオ医薬品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・非腫瘍バイオ医薬品の市場概観 ・非腫瘍バイオ医薬品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・非腫瘍バイオ医薬品の企業別販売動向、市場シェア、市場集中度、競争動向 ・非腫瘍バイオ医薬品の世界市場規模 ・非腫瘍バイオ医薬品の北米市場分析（アメリカ、カナダ、メキシコ等） ・非腫瘍バイオ医薬品のアメリカ市場規模推移 ・非腫瘍バイオ医薬品のカナダ市場規模推移 ・非腫瘍バイオ医薬品のメキシコ市場規模推移 ・非腫瘍バイオ医薬品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・非腫瘍バイオ医薬品のドイツ市場規模推移 ・非腫瘍バイオ医薬品のイギリス市場規模推移 ・非腫瘍バイオ医薬品のロシア市場規模推移 ・非腫瘍バイオ医薬品のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・非腫瘍バイオ医薬品の日本市場規模推移 ・非腫瘍バイオ医薬品の中国市場規模推移 ・非腫瘍バイオ医薬品の韓国市場規模推移 ・非腫瘍バイオ医薬品のインド市場規模推移 ・非腫瘍バイオ医薬品の東南アジア市場規模推移 ・非腫瘍バイオ医薬品の南米市場分析（ブラジル、アルゼンチン等） ・非腫瘍バイオ医薬品の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・非腫瘍バイオ医薬品の種類別分析/販売量、売上、市場シェア（生物製剤、バイオシミラー） ・非腫瘍バイオ医薬品の用途別分析/市場規模（） ・非腫瘍バイオ医薬品の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・非腫瘍バイオ医薬品の販売チャネル・代理店・貿易業者・ディーラー分析 |
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
Scope of the Report:
The global Non-oncology Biopharmaceuticals market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-oncology Biopharmaceuticals.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Non-oncology Biopharmaceuticals market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-oncology Biopharmaceuticals market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Novartis
Merck
Teva
Eli Lilly
Bristol-Myers Squibb
GlaxoSmithKline
UCB Pharma
Amgen
AbbVie
Takeda
AstraZeneca
Mylan
LEO Pharma
Boehringer Ingelheim
Alexion Pharmaceuticals
Elusys Therapeutics
Swedish Orphan Biovitrum
Biogen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biologics
Biosimilars
Market Segment by Applications, can be divided into
Immunology
Endocrinology
Others
Table of Contents
1 Non-oncology Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of Non-oncology Biopharmaceuticals
1.2 Classification of Non-oncology Biopharmaceuticals by Types
1.2.1 Global Non-oncology Biopharmaceuticals Revenue Comparison by Types (2019-2024)
1.2.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Types in 2018
1.2.3 Biologics
1.2.4 Biosimilars
1.3 Global Non-oncology Biopharmaceuticals Market by Application
1.3.1 Global Non-oncology Biopharmaceuticals Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Immunology
1.3.3 Endocrinology
1.3.4 Others
1.4 Global Non-oncology Biopharmaceuticals Market by Regions
1.4.1 Global Non-oncology Biopharmaceuticals Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024)
1.5 Global Market Size of Non-oncology Biopharmaceuticals (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Non-oncology Biopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Non-oncology Biopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Non-oncology Biopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Non-oncology Biopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novo Nordisk
2.5.1 Business Overview
2.5.2 Non-oncology Biopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Non-oncology Biopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Non-oncology Biopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva
2.8.1 Business Overview
2.8.2 Non-oncology Biopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Non-oncology Biopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.10 Bristol-Myers Squibb
2.10.1 Business Overview
2.10.2 Non-oncology Biopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.11 GlaxoSmithKline
2.11.1 Business Overview
2.11.2 Non-oncology Biopharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.12 UCB Pharma
2.12.1 Business Overview
2.12.2 Non-oncology Biopharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.13 Amgen
2.13.1 Business Overview
2.13.2 Non-oncology Biopharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.14 AbbVie
2.14.1 Business Overview
2.14.2 Non-oncology Biopharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.15 Takeda
2.15.1 Business Overview
2.15.2 Non-oncology Biopharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.16 AstraZeneca
2.16.1 Business Overview
2.16.2 Non-oncology Biopharmaceuticals Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.17 Mylan
2.17.1 Business Overview
2.17.2 Non-oncology Biopharmaceuticals Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.18 LEO Pharma
2.18.1 Business Overview
2.18.2 Non-oncology Biopharmaceuticals Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.19 Boehringer Ingelheim
2.19.1 Business Overview
2.19.2 Non-oncology Biopharmaceuticals Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.20 Alexion Pharmaceuticals
2.20.1 Business Overview
2.20.2 Non-oncology Biopharmaceuticals Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.21 Elusys Therapeutics
2.21.1 Business Overview
2.2.2 Non-oncology Biopharmaceuticals Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.22 Swedish Orphan Biovitrum
2.22.1 Business Overview
2.22.2 Non-oncology Biopharmaceuticals Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.23 Biogen
2.23.1 Business Overview
2.23.2 Non-oncology Biopharmaceuticals Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
3 Global Non-oncology Biopharmaceuticals Market Competition, by Players
3.1 Global Non-oncology Biopharmaceuticals Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-oncology Biopharmaceuticals Players Market Share
3.2.2 Top 10 Non-oncology Biopharmaceuticals Players Market Share
3.3 Market Competition Trend
4 Global Non-oncology Biopharmaceuticals Market Size by Regions
4.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Regions
4.2 North America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.3 Europe Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.5 South America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5 North America Non-oncology Biopharmaceuticals Revenue by Countries
5.1 North America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
5.2 USA Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5.3 Canada Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5.4 Mexico Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6 Europe Non-oncology Biopharmaceuticals Revenue by Countries
6.1 Europe Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
6.2 Germany Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.3 UK Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.4 France Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.5 Russia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.6 Italy Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries
7.1 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
7.2 China Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.3 Japan Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.4 Korea Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.5 India Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8 South America Non-oncology Biopharmaceuticals Revenue by Countries
8.1 South America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
8.2 Brazil Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8.3 Argentina Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8.4 Colombia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Non-oncology Biopharmaceuticals by Countries
9.1 Middle East and Africa Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
9.2 Saudi Arabia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.3 UAE Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.4 Egypt Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.5 Nigeria Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.6 South Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
10 Global Non-oncology Biopharmaceuticals Market Segment by Type
10.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Type (2014-2019)
10.2 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2019-2024)
10.3 Biologics Revenue Growth Rate (2014-2024)
10.4 Biosimilars Revenue Growth Rate (2014-2024)
11 Global Non-oncology Biopharmaceuticals Market Segment by Application
11.1 Global Non-oncology Biopharmaceuticals Revenue Market Share by Application (2014-2019)
11.2 Non-oncology Biopharmaceuticals Market Forecast by Application (2019-2024)
11.3 Immunology Revenue Growth (2014-2019)
11.4 Endocrinology Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Non-oncology Biopharmaceuticals Market Size Forecast (2019-2024)
12.1 Global Non-oncology Biopharmaceuticals Market Size Forecast (2019-2024)
12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Regions (2019-2024)
12.3 North America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.4 Europe Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.6 South America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Non-oncology Biopharmaceuticals Picture
Table Product Specifications of Non-oncology Biopharmaceuticals
Table Global Non-oncology Biopharmaceuticals and Revenue (Million USD) Market Split by Product Type
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Types in 2018
Figure Biologics Picture
Figure Biosimilars Picture
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Application (2014-2024)
Figure Non-oncology Biopharmaceuticals Revenue Market Share by Applications in 2018
Figure Immunology Picture
Figure Endocrinology Picture
Figure Others Picture
Table Global Market Non-oncology Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Non-oncology Biopharmaceuticals Type and Applications
Table Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Non-oncology Biopharmaceuticals Type and Applications
Table Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Non-oncology Biopharmaceuticals Type and Applications
Table Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Non-oncology Biopharmaceuticals Type and Applications
Table Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Non-oncology Biopharmaceuticals Type and Applications
Table Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Non-oncology Biopharmaceuticals Type and Applications
Table Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Non-oncology Biopharmaceuticals Type and Applications
Table Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Non-oncology Biopharmaceuticals Type and Applications
Table Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Non-oncology Biopharmaceuticals Type and Applications
Table Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Type and Applications
Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Non-oncology Biopharmaceuticals Type and Applications
Table GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table UCB Pharma Basic Information, Manufacturing Base and Competitors
Table UCB Pharma Non-oncology Biopharmaceuticals Type and Applications
Table UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Non-oncology Biopharmaceuticals Type and Applications
Table Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Non-oncology Biopharmaceuticals Type and Applications
Table AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Non-oncology Biopharmaceuticals Type and Applications
Table Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Non-oncology Biopharmaceuticals Type and Applications
Table AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Non-oncology Biopharmaceuticals Type and Applications
Table Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table LEO Pharma Basic Information, Manufacturing Base and Competitors
Table LEO Pharma Non-oncology Biopharmaceuticals Type and Applications
Table LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Type and Applications
Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Type and Applications
Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Elusys Therapeutics Basic Information, Manufacturing Base and Competitors
Table Elusys Therapeutics Non-oncology Biopharmaceuticals Type and Applications
Table Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Swedish Orphan Biovitrum Basic Information, Manufacturing Base and Competitors
Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Type and Applications
Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Non-oncology Biopharmaceuticals Type and Applications
Table Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Players (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Share by Players (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2017
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2018
Figure Global Top 5 Players Non-oncology Biopharmaceuticals Revenue Market Share in 2018
Figure Global Top 10 Players Non-oncology Biopharmaceuticals Revenue Market Share in 2018
Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Regions (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions in 2018
Figure North America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Europe Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure South America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table North America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
Table North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure USA Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Canada Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Mexico Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Europe Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Figure Europe Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Europe Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Germany Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure UK Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure France Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Russia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Italy Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure China Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Japan Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Korea Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure India Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table South America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019)
Table South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Brazil Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Argentina Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Colombia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Saudi Arabia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure UAE Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Egypt Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Nigeria Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure South Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Type (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Share by Type (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Type (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Type in 2018
Table Global Non-oncology Biopharmaceuticals Revenue Forecast by Type (2019-2024)
Figure Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2019-2024)
Figure Global Biologics Revenue Growth Rate (2014-2019)
Figure Global Biosimilars Revenue Growth Rate (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue by Application (2014-2019)
Table Global Non-oncology Biopharmaceuticals Revenue Share by Application (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Application (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue Share by Application in 2018
Table Global Non-oncology Biopharmaceuticals Revenue Forecast by Application (2019-2024)
Figure Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2019-2024)
Figure Global Immunology Revenue Growth Rate (2014-2019)
Figure Global Endocrinology Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Non-oncology Biopharmaceuticals Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Europe Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure South America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)
癌バイオ医薬品の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. C…- 世界の腫瘍アブレーション市場2019 Oncology ablation for cancer is a minimally invasive procedure that uses electrical energy and heat to destroy cancer cells. The global Oncology Ablation market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This repo…
- 世界の免疫腫瘍学アッセイ市場：市場規模・現状・予測 Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoin…
- RNA系バイオ医薬品市場：世界及び中国市場分析・予測（～2024年） RNA-based Biopharmaceuticals Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNA-based Biopharmaceuticals industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNA-based Bi…
- 生物製剤用使い捨て技術市場：世界及び中国市場分析・予測（～2024年） Single-Use Technology for Biopharmaceuticals Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Single-Use Technology for Biopharmaceuticals industry with a focus on the Chinese market. The report provides key statistics on the m…